Approval · Notice of Compliance 37582 · 2026
YESAFILI: Notice of Compliance 37582
Issued May 22, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37582
- Date
- May 22, 2026
- Company
- Biocon Biologics Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative – Change in Product Ownership
- Canadian reference product
- EYLEA
Products in this notice
Medicinal ingredients
- AFLIBERCEPT 2 MG per 0.05ML